Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (5y) (2016 - 2025)
Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.00 |
| Sep 30, 2025 | 87.00 |
| Jun 30, 2025 | 123.00 |
| Mar 31, 2025 | 161.00 |
| Dec 31, 2024 | 834.00 |
| Sep 30, 2024 | 819.00 |
| Jun 30, 2024 | 828.00 |
| Mar 31, 2024 | 869.00 |
| Dec 31, 2023 | -621.00 |
| Sep 30, 2023 | -633.00 |
| Jun 30, 2023 | -653.00 |
| Mar 31, 2023 | -648.00 |
| Dec 31, 2022 | 167.00 |
| Sep 30, 2022 | 199.00 |
| Jun 30, 2022 | 199.00 |
| Mar 31, 2022 | 294.00 |
| Dec 31, 2021 | 105.00 |
| Sep 30, 2021 | 135.00 |
| Jun 30, 2021 | 170.00 |
| Mar 31, 2021 | -74.00 |